Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Pharma Foods International Co., Ltd. ( (JP:2929) ) has provided an announcement.
Pharma Foods International Co., Ltd., a Tokyo Prime-listed health and functional foods company, focuses on developing high-value ingredients and products while expanding its market reach through R&D, new business creation, advertising, and strategic M&A. Its management philosophy emphasizes maximizing long-term shareholder value through a disciplined capital allocation framework.
The company’s board has approved an interim dividend of ¥12.50 per share with a January 31, 2026 record date, matching both the prior-year interim payout and its latest forecast. Funded from retained earnings and totaling ¥363 million, the dividend underscores management’s commitment to stable, predictable shareholder returns while continuing to invest aggressively in growth initiatives.
Dividend forecasts for the fiscal year call for a total annual payout of ¥25.00 per share, in line with the previous year’s full-year dividend. This consistency signals confidence in the company’s operational momentum and financial position, providing investors with visibility on cash returns even as Pharma Foods accelerates its growth-focused spending.
The most recent analyst rating on (JP:2929) stock is a Hold with a Yen655.00 price target. To see the full list of analyst forecasts on Pharma Foods International Co., Ltd. stock, see the JP:2929 Stock Forecast page.
More about Pharma Foods International Co., Ltd.
Pharma Foods International Co., Ltd., listed on the Tokyo Stock Exchange Prime Market, operates in the health and functional foods sector, focusing on developing and marketing value-added ingredients and related products. The company emphasizes research and development, new business creation, advertising, and strategic M&A to expand its addressable market and deepen customer engagement over the long term.
Its capital allocation strategy aims to balance high-growth investment with profitability, while providing stable and predictable shareholder returns via consistent dividends. This approach underpins its efforts to maximize long-term shareholder value and maintain robust financial health as it pursues expansion opportunities in its core and adjacent markets.
Average Trading Volume: 209,254
Technical Sentiment Signal: Sell
Current Market Cap: Yen19.03B
For detailed information about 2929 stock, go to TipRanks’ Stock Analysis page.